DE60330011D1 - MSP-3-ähnliche Genfamilie - Google Patents
MSP-3-ähnliche GenfamilieInfo
- Publication number
- DE60330011D1 DE60330011D1 DE60330011T DE60330011T DE60330011D1 DE 60330011 D1 DE60330011 D1 DE 60330011D1 DE 60330011 T DE60330011 T DE 60330011T DE 60330011 T DE60330011 T DE 60330011T DE 60330011 D1 DE60330011 D1 DE 60330011D1
- Authority
- DE
- Germany
- Prior art keywords
- family
- msp
- gene
- gene family
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 101150067969 MSP-3 gene Proteins 0.000 abstract 1
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 208000037369 susceptibility to malaria Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03292673A EP1526178B1 (de) | 2003-10-24 | 2003-10-24 | MSP-3-ähnliche Genfamilie |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60330011D1 true DE60330011D1 (de) | 2009-12-24 |
Family
ID=34384722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60330011T Expired - Lifetime DE60330011D1 (de) | 2003-10-24 | 2003-10-24 | MSP-3-ähnliche Genfamilie |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070098738A1 (de) |
EP (2) | EP1526178B1 (de) |
CN (1) | CN1898384A (de) |
AT (1) | ATE448307T1 (de) |
AU (1) | AU2004283891B2 (de) |
BR (1) | BRPI0415784A (de) |
CA (1) | CA2542924A1 (de) |
CY (1) | CY1110630T1 (de) |
DE (1) | DE60330011D1 (de) |
DK (1) | DK1526178T3 (de) |
ES (1) | ES2335094T3 (de) |
PT (1) | PT1526178E (de) |
SI (1) | SI1526178T1 (de) |
WO (1) | WO2005040203A2 (de) |
ZA (1) | ZA200603296B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
US20030161840A1 (en) * | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
EP2223937A1 (de) * | 2009-02-27 | 2010-09-01 | Institut Pasteur | Polypeptide zur Vorbeugung oder Behandlung von Malaria |
FR2968560A1 (fr) * | 2010-12-13 | 2012-06-15 | Oreal | Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu |
CN109295243A (zh) * | 2018-12-14 | 2019-02-01 | 中国疾病预防控制中心寄生虫病预防控制所 | 鉴定间日疟原虫PvMSP-3α基因多态性的引物、方法及应用 |
CN113150101A (zh) * | 2021-04-23 | 2021-07-23 | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | 一种恶性疟原虫RIFIN重组蛋白PfRIFIN-55的构建、制备及用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2744724B1 (fr) * | 1996-02-14 | 2002-08-02 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
-
2003
- 2003-10-24 DK DK03292673.5T patent/DK1526178T3/da active
- 2003-10-24 AT AT03292673T patent/ATE448307T1/de active
- 2003-10-24 PT PT03292673T patent/PT1526178E/pt unknown
- 2003-10-24 DE DE60330011T patent/DE60330011D1/de not_active Expired - Lifetime
- 2003-10-24 EP EP03292673A patent/EP1526178B1/de not_active Expired - Lifetime
- 2003-10-24 ES ES03292673T patent/ES2335094T3/es not_active Expired - Lifetime
- 2003-10-24 SI SI200331739T patent/SI1526178T1/sl unknown
-
2004
- 2004-10-22 WO PCT/EP2004/012909 patent/WO2005040203A2/en active Application Filing
- 2004-10-22 CN CNA2004800386552A patent/CN1898384A/zh active Pending
- 2004-10-22 BR BRPI0415784-2A patent/BRPI0415784A/pt not_active IP Right Cessation
- 2004-10-22 AU AU2004283891A patent/AU2004283891B2/en not_active Ceased
- 2004-10-22 CA CA002542924A patent/CA2542924A1/en not_active Abandoned
- 2004-10-22 EP EP04791104A patent/EP1689866A2/de not_active Withdrawn
-
2006
- 2006-04-24 US US11/409,174 patent/US20070098738A1/en not_active Abandoned
- 2006-04-25 ZA ZA2006/03296A patent/ZA200603296B/en unknown
-
2010
- 2010-01-05 CY CY20101100018T patent/CY1110630T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1898384A (zh) | 2007-01-17 |
BRPI0415784A (pt) | 2006-12-26 |
WO2005040203A2 (en) | 2005-05-06 |
CY1110630T1 (el) | 2015-04-29 |
CA2542924A1 (en) | 2005-05-06 |
US20070098738A1 (en) | 2007-05-03 |
DK1526178T3 (da) | 2010-01-18 |
ES2335094T3 (es) | 2010-03-22 |
HK1075066A1 (en) | 2005-12-02 |
WO2005040203A3 (en) | 2005-06-23 |
EP1526178A1 (de) | 2005-04-27 |
EP1689866A2 (de) | 2006-08-16 |
PT1526178E (pt) | 2010-02-03 |
EP1526178B1 (de) | 2009-11-11 |
ATE448307T1 (de) | 2009-11-15 |
SI1526178T1 (sl) | 2010-03-31 |
ZA200603296B (en) | 2007-10-31 |
AU2004283891A1 (en) | 2005-05-06 |
AU2004283891B2 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214460A0 (en) | Malaria prime/boost vaccines | |
WO2020128031A3 (en) | Rna for malaria vaccines | |
IN2014DN08830A (de) | ||
WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
CY1113078T1 (el) | Συνθεση πολυσθενους εμβολιου | |
SG156535A1 (en) | Recombinant viral-based malaria vaccines | |
UA93508C2 (en) | Anti-malaria vaccine | |
MA30581B1 (fr) | Vaccin viral recombinant | |
WO2006113214A3 (en) | Vaccine against pandemic strains of influenza viruses | |
IL174653A0 (en) | Promoters for expression in modified vaccinia virus ankara | |
MX2010001752A (es) | Vacunas. | |
DK1356822T3 (da) | Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener | |
CY1110630T1 (el) | Οικογενεια γονιδιων παρομοιων με τα msp-3 | |
BRPI0515334A (pt) | uso de um antìgeno de plasmodium | |
WO2008086386A3 (en) | Adenoviral vector-based malaria vaccines | |
EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
DK1599225T3 (da) | Sammensætninger og fremgangsmåder til frembringelsen af beskyttende immunrespons mod malaria | |
WO2007006052A3 (en) | Malaria msp-1 c-terminal enhanced subunit vaccine | |
DK1697405T3 (da) | LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria | |
ATE455854T1 (de) | Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria | |
WO2002092628A3 (fr) | Antigenes de plasmodium falciparum et leurs applications vaccinales et diagnostiques | |
HK1097277A (en) | Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria | |
BRPI0924581A2 (pt) | seqüências geneticamente modificadas de antígenos de plasmodium vivax, composições vacinais contendo proteínas recombinantes e vírus recombinantes que expressam esses antígenos e método de vacinação dose-reforço contra malária | |
ITMI20020433A0 (it) | Epitopi antigenici di gp100/pme117 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |